Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study

NCT00637065 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Hypertension
Interstitial Lung Disease
Idiopathic Pulmonary Fibrosis
Nonspecific Interstitial Pneumonia

Interventions

DRUG: Bosentan
DRUG: Placebo

Sponsor

Royal Brompton & Harefield NHS Foundation Trust

Collaborators

[object Object]